Tweenvest Stocks

Subgen AI AB (publ) (OM: SUBGEN)

Health Care · Biotechnology · SE

Skr0.04

-18.08% today · -100.0% 1Y

Subgen AI AB (publ) (OM: SUBGEN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $10.83M and employs 251 people.

Over the last twelve months the share price has lost 100.0%, trading between 0.03 and 19.60.

Tweenvest scores Subgen AI AB (publ) across four factors: quality 59/100. Its strongest factor is quality.

SUBGEN price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$10.83M
Revenue (TTM)
$22.12M
P/E
EPS
-0.05
Dividend yield
Beta (5Y)
52-week high
Skr19.60
52-week low
Skr0.03
Avg volume (3M)
Shares outstanding
1.98B
Employees
251
Next earnings

About Subgen AI AB (publ)

Subgen AI AB develops artificial intelligence-based models and applications to control data for government and businesses. The company engages in the provision of information society services aimed at delivering financial and related knowledge tools to facilitate third-party access to financial literacy and instruments that enable them to interpret such information through e-learning; the acquisition, ownership, management and administration of securities; and the acquisition, ownership, marketing, leasing and operation of rural or urban properties. It also provides financial intermediation services; computer programming activities, structure and content design, writes computer code for systems, computer software, databases and web pages; and customizes computer programs, including configuration and modification of legacy programs. In addition, the company offers marketing and after-sales services of diagnostic imaging machinery and human resources services, as well as development of state-of-the-art artificial intelligence (Al) systems. Further, it provides Serenity Star, AI4D core, and Substrate Cloud. The company is based in London, United Kingdom. Subgen AI AB operates as a subsidiary of Substrate Artificial Inteligence, S.A.

ISIN
SE0026820854
Listed since
Dec 10, 2025
Exchange
OMX Nordic Exchange Stockholm
Currency
SEK
CompanyMarket capPriceDay
AbbVie Inc.NYSE: ABBV$469.68B$265.79+0.48%
Amgen Inc.NasdaqGS: AMGN$239.09B$442.24-0.36%
Gilead Sciences, Inc.NasdaqGS: GILD$184.47B$148.77+1.38%
Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX$140.13B$552.85+0.96%
Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN$83.24B$833.56+0.61%
argenx SEENXTBR: ARGX$64.17B879.20+1.74%
Moderna, Inc.NasdaqGS: MRNA$63.41B$158.83+14.36%
CSL LimitedASX: CSL$59.49BAU$173.64+2.68%

Browse every Biotechnology company →

Figures last refreshed Aug 18, 2026.